ARAY Reports Record Revenue, PTIE Bleeds, EVOK To Face FDA In April

Today's Daily Dose brings you news about Accuray's financial results; stock offerings of AVEO and Pain Therapeutics; Evoke Pharma's upcoming regulatory catalyst in April and FDA approval for expanded indication for Eisai/Merck's Lenvatinib.

from RTT - Biotech https://ift.tt/2MTrTai
via IFTTT